App-Quantinova.ai

Association Between Serum Fabp4 Levels, Pericardial Adipose Tissue Volume, and Plaque Characteristics in Patients With Type 2 Diabetes Mellitus

Keiko Kawai-Kowase - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

N/A

Prevalence and Clinical Impact of Normalization of Left Ventricular Ejection Fraction After Optimal Pharmacotherapy in Patients With Nonischemic Dilated Cardiomyopathy

Takayuki Inomata - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Dilated cardiomyopathy

N/A

Late Gadolinium Enhancement in Magnetic Resonance Imaging has a Strong Relation with Microvascular Dysfunction and TransCardiac Troponin T Release in Non-Ischemic Heart Failure Patients

Seiji Takashio - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Microvascular dysfunction

Adenosine

B-Type Natriuretic Peptide: Age and Gender Specific for Risk Stratification in the General Population - The Heinz Nixdorf Recall Study

Amir Abbas Mahabadi - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Chronic kidney disease

N/A

Profiling Determinants Reflective of Heart Failure and Matrix Remodeling Stratify Patients Presenting With Acute Dyspnea and Early Hospital Readmission

Sean Collins - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Congestive heart failure

TIMP-2

Effectiveness of Adaptive Servo-Ventillation for the Prevention of Atrial fibrillation Recurrence after Radiofrequency Catheter Ablation

Koji Kumagai - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

N/A

Usefulness of N-Terminal Pro B-Type Natriuretic Peptide to Predict Survival in Patient with Low Flow, Low Gradient Aortic Stenosis with Reduced LV Ejection Fraction

Philippe Pibarot - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Coronary Artery Disease

Dobutamine

ANX-042, a Novel Natriuretic Peptide (NP), is Safe and Stimulates Cyclic Guanosine Monophosphate (cGMP) in Healthy Volunteers

Robert D Simari - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute decompensated heart failure

Angiotensin II

Clinical Significance of the Late Gadolinium Enhancement Patterns of Cardiovascular Magnetic Resonance to Predict Prognosis in Dilated Cardiomyopathy

Takayuki Inomata - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Ventricular arrhythmias

N/A

Prognostic Value of Combination of High-Sensitivity Troponin T and B-Type Natriuretic Peptide in Outpatients With Type 2 Diabetes Mellitus

Junnichi Ishii - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

N/A

Prognostic Value of Serum Levels of Neutrophil Gelatinase-Associated Lipocalin on Admission in Patients Hospitalized to Coronary Care Units

Junnichi Ishii - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Acute Coronary Syndromes

N/A

Favorable Effects of Multi-Electrode Catheter-Based Renal Sympathetic Denervation on Left Ventricular Mass, Diastolic Function and Neurohormonal Activation in Resistant Hypertension

Kyriakos Dimitriadis - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertension

N/A

Multiple Biomarkers Improve the Prediction of Cardiovascular Mortality in Patients on Chronic Hemodialysis

Ryunosuke Okuyama - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

N/A

NT-proBNP but Not Soluble Corin Levels Were Associated With Preeclampsia in Pregnancy-Associated Hypertension

Tracy Kovach - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Pregnancy-Induced Hypertension

N/A

Lipoprotein (a) Does Not Show Significant Effect for the Development of Aortic Stenosis in Japanese

Osamu Yasuda - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Aortic stenosis

N/A

The Addition of B-Type Natriuretic Peptide to the Intermountain Risk Score Improves the Predictive Ability for Mortality Among Patients Undergoing Angiography

Jeffrey L Anderson - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Left ventricular dysfunction

N/A

Circulation Levels of Vasopressin for Patients in Hyper Acute Phase of Acute Coronary Syndromes

Yasuyuki Suzuki - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

vasopressin Injection

Glomerular Filtration Rate Estimated by Cystatin C-Based versus Creatinine-Based Equations for Predicting Mortality in Outpatients With Type 2 Diabetes Mellitus

Junnichi Ishii - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

N/A

Decreased Plasma Levels of Active Glucagon-Like Peptide-1 Correlate With Heart Failure

Seigo Sugiyama - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

Intranasal glucagon

Advanced Peripheral Endothelial Dysfunction Rather Than Increased Aortic Stiffness Correlates With Left Ventricular Diastolic Dysfunction and Heart Failure With Preserved Left Ventricular Ejection Fraction in Patients With Diabetes Mellitus

Seigo Sugiyama - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Left ventricular diastolic dysfunction

N/A

Filters

387 Abstracts